GoodRx to Participate in Upcoming Investor Conferences
04 Novembre 2024 - 10:05PM
Business Wire
GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the
“Company”), the leading prescription savings platform in the U.S.,
today announced that executives from the Company will participate
in a fireside chat at each of the following investor
conferences:
- UBS 2024 Global Healthcare Conference in Rancho Palos Verdes,
CA, on Tuesday, November 12, 2024 at 2 p.m. Eastern Time (11 a.m.
Pacific Time)
- Citi 2024 Global Healthcare Conference in Miami, FL, on
Thursday, December 5, 2024 at 8:45 a.m. Eastern Time (5:45 a.m.
Pacific Time)
A live webcast of each of the foregoing events will be available
on the Company's Investor Relations website,
https://investors.goodrx.com/. Following each conference, an
archived recording will be available on the Company’s website for
at least 30 days.
About GoodRx
GoodRx is the leading prescription savings platform in the U.S.
Trusted by more than 25 million consumers and 750,000 healthcare
professionals annually, GoodRx provides access to savings and
affordability options for generic and brand-name medications at
more than 70,000 pharmacies nationwide, as well as comprehensive
healthcare research and information. Since 2011, GoodRx has helped
consumers save over $75 billion on the cost of their
prescriptions.
GoodRx periodically posts information that may be important to
investors on its investor relations website at
https://investors.goodrx.com. We intend to use our website as a
means of disclosing material non-public information and for
complying with our disclosure obligations under Regulation FD.
Accordingly, investors and potential investors are encouraged to
consult GoodRx’s website regularly for important information, in
addition to following GoodRx’s press releases, filings with the
Securities and Exchange Commission and public conference calls and
webcasts. The information contained on, or that may be accessed
through, GoodRx’s website is not incorporated by reference into,
and is not a part of, this press release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241104739401/en/
Investor Contact GoodRx Aubrey Reynolds ir@goodrx.com
Press Contact GoodRx Lauren Casparis
lcasparis@goodrx.com
GoodRx (NASDAQ:GDRX)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
GoodRx (NASDAQ:GDRX)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024